有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Danofloxacin mesylate;CP-76136-27;Advocin
Chemical Name 1-Cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate
CAS 119478-55-6
Related CAS 112398-08-0 (free base)
Formula C20H24FN3O6S
Structure
Formula Weight 453.49318
Stage II 期临床
Company Pfizer (Originator)
Activity/Mechanism Antibacterial Drugs, ANTIINFECTIVE THERAPY, Quinolones
Syn. Route 1
Route 1
danofloxacin (xi) is synthesized by the addition of (1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptane (vii) and 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (x), and further converted to its monomethanesulfonate salt as outlined in scheme 17912701a:the diazabicycloalkane sidechain (vii) is prepared in one of two ways, both routes starting with trans-4-hydroxy-l-proline (i). in the first sequence, the amino acid (i) is selectively monotosylated on nitrogen by stirring an aqueous solution of (i) in the presence of p-toluenesulfonyl chloride (tscl) with sodium carbonate as base. the monotosylate (ii) is then reduced to the diol (iii) with diborane generated in situ. the diol (iii) is next converted to either the tritosylate (iv) selectively or to a mixture of (iv) and the monochloride (v) by treatment with excess tscl in pyridine at either 0 c or room temperature, respectively. either pure (iv) or a mixture of (iv) and (v) can be cyclized equally well to the bicyclic intermediate (vi) by treatment with methylamine in a sealed container. finally, (vi) can be deprotected to give the desired (1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptane (vii) in excellent overall yield by treatment with 30% anhydrous hydrogen bromide in acetic acid.by an alternative route, (i) is esterified under fischer conditions and treated with excess p-toluenesulfonyl chloride in the presence of pyridine and triethylamine. the resulting ester (viii) is then treated with methylamine to obtain the amide (ix), which is reductively cyclized with lithium aluminum hydride to the bicyclic intermediate (vi). finally, (vi) is deprotected as described above to give (vii). the reaction of (1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptane (vii) with 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (x) to give danofloxacin free base (xi) is effected by the action of 1,8-diazabicyclo[5.4.0]undec-7-ene (dbu) in pyridine. conversion of (xi) to danofloxacin mesylate using one equivalent of methanesulfonic acid in ethanol completes the synthesis.
List of intermediates No.
2-[5-(bis(benzoyloxy)[bis[1-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-1h-indol-5-yl]]-lambda(5)-bismuthanyl)-1h-indol-1-yl]ethyl tert-butyl(dimethyl)silyl ether (i)
3-amino-2-thiophenecarboxamide (ii)
pentanoic anhydride (iii)
2-butylthieno[3,2-d]pyrimidin-4(3h)-one (iv)
2-butyl-4-chlorothieno[3,2-d]pyrimidine (v)
3-amino-2-thiophenecarboxylic acid methyl ester; methyl 3-amino-2-thiophenecarboxylate (vi)
3-amino-2-thiophenecarboxylic acid (vii)
4-(2,4-dichlorophenyl)-3-methyl-1h-pyrazol-5-amine (viii)
3-(2,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7(4h)-one (ix)
7-chloro-3-(2,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine (x)
benzyl (2s)-2-amino-5-methylhexanoate (xi)
Reference 1:
    fox, d.e.; braish, t.f.; synthesis of (s,s)- and (r,r)-2-alkyl-2,5-diazabicyclo[2.2.1]heptanes. j org chem 1990, 55, 1684-7.
Reference 2:
    braish, t.f.; fox, d.e. (pfizer inc.); process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1)heptanes. us 5013839 .
Reference 3:
    mcguirk, p.r.; jefson, m.r.; mann, d.d.; et al.; synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine. j med chem 1992, 35, 4, 611.
Reference 4:
    jefson, m.r.; shryock, t.r.; schaaf, t.k.; mcguirk, p.r.; the synthesis and antibacterial activity of danofloxacin (cp-76,136): a new quinolone for veterinary medicine. 29th intersci conf antimicrob agents chemother (sept 17-20, houston) 1989, abst 1187.
Reference 5:
    mcguirk, p.r.; jefson, m.r.; danofloxacin mesylate. drugs fut 1992, 17, 2, 93.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名甲磺酸达氟沙星;英文名Danofloxacin mesylate;CP-76136-27;Advocin;CAS[119478-55-6]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
新农药登记需要注意哪些问题?
2018年除草剂登记数量领先,
江苏省严查严管危废处置,保障环
年报!正邦科技净利润或同比下降
中山化工嘧菌酯/灭草松/啶酰菌
红太阳子公司重庆华歌生化投资设
吲唑磺菌胺化合物专利已经届满,
2019年上海市推荐农药品种及
预增!江山/新安2018年净利
国光股份募集资金投资项目变更实
安道麦与辉丰签署备忘录,拟收购
恭喜!这3家企业入围第25批国
科迪华旗下喹禾灵除草剂产品线被
民族骄傲!氰烯菌酯再获国家科学
BMS 白血病药物组合 Spr
增加至7000万!国光股份子公
农药领域的行政许可事项相互之间
暂停?不存在的!2019年将全
多个植保农药类项目拟提名201
又有多项植保农药类成果拟提名2
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明